Plasmodium vivax can cause severe malaria associated with substantial morbidity and mortality, show two studies published in PLoS Medicine. These findings challenge the current dogma that P.

A new evidence-based global distribution map of Plasmodium vivax malaria is used to estimate that 2.85 billion people lived at risk of infection with this parasite in 2009. A new evidence-based global ...

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission.

Background. Evidence of the presence of Plasmodium vivax in the placenta is scarce and inconclusive. This information is relevant to understanding whether P. vivax affects placental function and how ...

Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University ...

Experts want closer attention to plasmodium vivax parasite in the fight against malaria. The complete sequence of the vivax genome has now been reported. Experts want closer attention to plasmodium ...

Plasmodium vivax is a major cause of malaria morbidity worldwide yet has remained genetically intractable. To stably modify this organism, we used zinc-finger nucleases (ZFNs), which take advantage of ...

New study highlights an innovative approach towards developing a vaccine against Plasmodium vivax malaria. A novel study indicates promising avenues in an innovative approach for developing a vaccine ...

Proteins derived from the latent liver stage of Plasmodium vivax can be detected in small extracellular vesicles that circulate in blood, according to a study led by ISGlobal, an institution supported ...

The horizontal transfer of DNA between different organisms is a major force shaping the genomes of prokaryotes, but is considered to have a minor role in eukaryotes, with only a handful of known ...